• Innovations in In Vitro Drug Response Evaluation for Cancer

  2026-04-22

  Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drugs in vitro by distinguishing between relative and fractional cell viability. This dual-metric approach provides nuanced insights into how compounds like Axitinib (AG 013736) modulate proliferation and cell death, improving the predictive value of preclinical models for cancer therapy.

• Imeglimin Enhances Mitochondrial Function in CTS SSCT Cells

  2026-04-22

  This study demonstrates that Imeglimin improves mitochondrial function and reduces oxidative stress in subsynovial connective tissue-derived cells from patients with idiopathic carpal tunnel syndrome. These findings support the role of mitochondrial health in disease progression and highlight new avenues for targeted interventions.

• Molecular Epidemiology and Pathogenicity of C. auris in Guan

  2026-04-21

  This study provides one of the first comprehensive molecular epidemiological analyses of Candidozyma auris isolates in South China, detailing clade distribution, antifungal resistance mechanisms, and virulence factors. Findings inform local infection control strategies and highlight methodological approaches applicable to emerging multidrug-resistant fungal pathogens.

• Pepstatin A in Modern Research: Precision Inhibition and New

  2026-04-21

  Explore how Pepstatin A, a leading aspartic protease inhibitor, is reshaping cardiovascular and cellular research with advanced mechanistic insights. This article delivers a comprehensive, evidence-driven perspective not found in standard guides.

• SP2509: Lysine-Specific Demethylase 1 Antagonist for AML Res

  2026-04-20

  SP2509 is a highly selective Lysine-specific demethylase 1 antagonist that empowers researchers to dissect and therapeutically target cancer epigenetics, especially in acute myeloid leukemia. This article provides actionable workflows, troubleshooting guidance, and comparative advantages to accelerate translational discovery.

• CD28-ARS2 Axis Drives PKM Splicing for T Cell Metabolic Flex

  2026-04-20

  Holling et al. reveal that CD28 signaling in CD8+ T cells upregulates ARS2, which orchestrates alternative splicing of pyruvate kinase (PKM), favoring the PKM2 isoform and enabling metabolic flexibility essential for antitumor immunity. These findings clarify a critical mechanism by which T cells adapt their metabolism, with implications for immunotherapy and metabolic profiling.

• Escitalopram in Translational Neuroscience: Strategy & Mecha

  2026-04-19

  Explore how Escitalopram (Lexapro) advances antidepressant and anxiolytic research. This article blends mechanistic insights with strategic guidance for translational scientists, referencing the latest clinical findings, robust protocol parameters, and APExBIO’s high-purity Escitalopram’s unique value. Go beyond standard product pages with a vision for next-generation serotonergic research.

• Chronic 40 Hz Light Flicker Attenuates Epileptogenesis via d

  2026-04-18

  This study demonstrates that chronic 40 Hz light flicker (GENUS) can reduce epileptogenesis in a mouse model by strengthening gamma oscillations through a defined visual circuit involving the dorsal lateral geniculate nucleus (dLGN) shell. The findings highlight a non-invasive approach to modulate neuronal networks relevant for epilepsy, with implications for circuit-specific research and chemogenetic modulation strategies.

• 2,5-di-tert-butylbenzene-1,4-diol: Optimizing SERCA Inhibiti

  2026-04-17

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) from APExBIO stands out as a robust, selective SERCA inhibitor, empowering next-generation calcium signaling and stem cell mobilization assays. This article provides actionable workflow protocols, troubleshooting insights, and advanced application strategies for bench researchers seeking reproducibility and translational impact.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-04-16

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly sensitize tumors to ultra-high dose rate FLASH radiotherapy by boosting reactive oxygen species and DNA double-strand breaks, resulting in improved antitumor effects and immune activation. The work provides a mechanistic rationale and preclinical evidence for combining radiosensitizing nanoparticles with FLASH-RT to overcome its current limitations in tumor control.

• Coumestrol: Phytoestrogen Estrogen Receptor Antagonist in RA

  2026-04-15

  Coumestrol stands out as a selective phytoestrogen estrogen receptor antagonist, offering researchers a robust tool for dissecting nuclear receptor pathways and inducing ferroptosis in autoimmune models. This article translates the latest mechanistic findings into practical workflows, troubleshooting guidance, and protocol optimizations for leveraging Coumestrol (SKU C5832, APExBIO) in advanced selective estrogen receptor modulator (SERM) studies.

• Escitalopram in Molecular Psychiatry: Selectivity, Assay Pre

  2026-04-14

  Explore the molecular selectivity and translational importance of Escitalopram in advanced antidepressant research. This article uncovers nuanced assay strategies and integrates recent clinical findings to guide rigorous, reproducible study design.

• Linoleic Acid–PPARα–TF Axis Drives Tumor Progression in pLEL

  2026-04-13

  This study uncovers how linoleic acid induces tissue factor (TF) expression via PPAR-α activation, altering the tumor microenvironment and promoting progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC). The findings highlight the mechanistic role of lipid metabolism in rare lung cancer and suggest TF as a potential therapeutic target.

• Substance P (B6620): Technical Guide for Pain and Immune Res

  2026-04-13

  Substance P (SKU B6620) is a high-purity tachykinin neuropeptide for targeted research on pain transmission, immune modulation, and inflammation. This guide outlines practical handling, assay setup, and troubleshooting, helping researchers avoid common stability and solubility pitfalls. It is not intended for diagnostic or therapeutic applications beyond its defined research scope.

• Nonivamide: Bridging TRPV1 Mechanisms to Translational Impac

  2026-04-12

  Explore how Nonivamide, a capsaicin analog and selective TRPV1 agonist, is redefining translational research by uniting anti-proliferative and neuroimmune pathways. This article unpacks recent mechanistic breakthroughs, experimental protocols, and strategic guidance—grounded in rigorous evidence—to empower oncology and inflammation researchers.

15651 records 1/1044 page Next 12345 下5页 Last page